SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 70.19+2.8%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (416)10/21/2003 11:45:55 AM
From: JMarcus  Read Replies (1) of 3722
 
AVGN is trading at $7.05. Yesterday it almost sold off on news about progress in getting the IND for the Parkinson's gene therapy vector, but then AG Edwards announced an upgrade from Neutral to Buy and the stock resumed its upward trend. Per your post #416, the next level of resistance should be in the $7.75 range.

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext